» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- Dalhousie’s first physician assistant cohort steps into Nova Scotia’s healthcare system
- Dalhousie med students explore pediatric care in Austria
- Dalhousie researchers shine at Discovery Awards with four top honours
- New $2M national study to uncover how biology, social factors shape MS outcomes
- Pathology EDIA Committee makes strides during 2024‑2025 year
- CCfV’s impact on vaccine innovation
- Unlocking the secrets of memory—with fruit flies
- Celebrating mobility research and the power of philanthropy